Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
News
News
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
IASLC Journals Share Exciting Milestones on Metrics Journeys
lungcanc
The Chen-Huang Center for EGFR-Mutant Lung Cancers Represents a ‘Concentrated and Focused Effort’ in Studying This Disease Subset
Breaking News Briefs
Anne-Marie Baird, BSc, PhD
Paul G. Kluetz, MD
Cancer Research Innovator, Trailblazer, and Mentor Dr. Waun Ki Hong Dies
lungcanc
Dr. Fred R. Hirsch Departs IASLC CEO Role, Joins Mount Sinai...
lungcanc
James P. Allison and Tasuku Honjo Jointly Awarded the Nobel Prize...
lungcanc
Antoinette Wozniak, MD
lungcanc
Raymond Osarogiagbon, MBBS, FACP
lungcanc
Dr. James D. Cox
lungcanc
Vassiliki A. Papadimitrakopoulou, MD
lungcanc
Dr. David J. Sugarbaker
lungcanc
Jessica S. Donington, MD, MSCR
lungcanc
Avrum Spira, MD
lungcanc
1
2
3
4
...
13
Page 3 of 13
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
